Preclinical studies of antiviral activity of the RPH-137 fusion protein and molnupiravir against COVID-19

Preclinical studies of antiviral activity of the RPH-137 fusion protein and molnupiravir against COVID-19

Finding effective and safe medicines to fight SARS-CoV-2 infection is an urgent task. RPH-137 is an original trap fusion protein against SARS-CoV-2 virus. It comprises the angiotensin-converting enzyme type 2 extracellular domain and the human IgG1 Fc fragment.The aim of the study was to carry out a...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Shipaeva, O. V. Filon, A. V. Zintchenko, G. A. Shipunov, A. A. Dmitrieva, M. S. Lemak, S. A. Grishin, E. I. Trofimets, K. L. Kryshen, L. I. Kozlovskaya, A. S. Lunin, V. D. Apolokhov, S. F. Barbashov, Ya. V. Lavrovsky, M. Yu. Samsonov
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-12-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	sars-cov-2 molnupiravir rph-137 vero cell culture syrian hamsters efficacy rt-pcr
Online Access:	https://www.biopreparations.ru/jour/article/view/437
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS
by: V. B. Vasilyuk, et al.
Published: (2023-02-01)

Comparison of the quality of beef from Jagalan RPH Production and Non-RPH Production
by: Ayu Pramudita, et al.
Published: (2025-06-01)

Determining Prostate Cancer-Related Pathways and the Role of the RPH3AL Gene
by: Ömer Faruk Bayrak, et al.
Published: (2024-12-01)

Effect of Ruiyun procedure for hemorrhoids (RPH-4) for treating mixed hemorrhoids
by: Yao Qixian, et al.
Published: (2022-06-01)

Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2024-03-01)

Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial
by: T. N. Komarov, et al.
Published: (2024-03-01)

Degree-Based and Neighborhood Degree Sum-Based Entropy Measures of Molnupiravir
by: Shibsankar Das, et al.
Published: (2025-06-01)

Molnupiravir's real-world effectiveness in COVID-19 outpatients at high risk of severe disease: a single-center study
by: Ivana I Gmizic, et al.
Published: (2024-05-01)

Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study
by: Guozhang Lin, et al.
Published: (2025-02-01)

Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19
by: Samuel Theodorus Sutanto, et al.
Published: (2023-01-01)

Comparison of the effect of PPH double purse-string suture and RPH series ligation in elderly patients with Ⅲ-Ⅳ degree prolapsed hemorrhoids
by: Li Qianguo, et al.
Published: (2023-02-01)

Real-world effectiveness and economic analysis of nirmatrelvir/ritonavir, remdesivir, and molnupiravir for treatment of COVID-19 among ambulatory patients in Thailand
by: Sirapat Korwiwattanakan, et al.
Published: (2025-08-01)

The effect of molnupiravir and nirmatrelvir on SARS-CoV-2 genome diversity in severe models of COVID-19
by: Rebekah Penrice-Randal, et al.
Published: (2025-05-01)

Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation
by: Yuchen Wei, et al.
Published: (2025-12-01)

A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus
by: Mickie H. Cheng, et al.
Published: (2025-04-01)

Safety and tolerability of molnupiravir and nirmatrelvir/ritonavir in patients with advanced chronic kidney disease and kidney failure; a cohort study
by: Rani Sawtell, et al.
Published: (2025-12-01)

Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study)
by: Ivan Gentile, et al.
Published: (2025-03-01)

Long-term goflkicept therapy for patients with idiopathic recurrent pericarditis: results of the interim analysis of an ongoing open-label extension study
by: Valentina Yu. Myachikova, et al.
Published: (2024-10-01)

Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS
by: T. N. Komarov, et al.
Published: (2023-02-01)

Effect of new antitumor compounds based on azoloazine derivatives on the level of DNA damage in normal Vero cells in the DNA comet test
by: A. H. Al-Humairi, et al.
Published: (2024-01-01)

CURRENT ASPECTS OF ETIOTROPIC COVID-19 THERAPY
by: D. N. Zemskov, et al.
Published: (2022-12-01)

Study of Riamilovir Activity Against SARS-CoV-2 Infection In Syrian Hamsters
by: S. V. Chepur, et al.
Published: (2021-10-01)

Study of a tick-borne encephalitis vaccine
by: O. V. Stronin, et al.
Published: (2023-10-01)

Pathomorphological changes in the lung tissues of Syrian hamsters during experimental infection with SARS‐COV‐2
by: L. V. Shestopalova, et al.
Published: (2024-10-01)

Carboxylesterase Factors Influencing the Therapeutic Activity of Common Antiviral Medications Used for SARS-CoV-2 Infection
by: Yue Shen, et al.
Published: (2025-06-01)

Histological study of testis of golden hamster (Mesocricetus auratus) in different ages during postnatal development
by: Qassim Abbas Mohammed, et al.
Published: (2025-03-01)

The Common Hamster Cricetus cricetus L., 1758 in Western Siberia: the species’ past, present and future
by: N. S. Moskvitina, et al.
Published: (2022-07-01)

Effect of Panavir on Herpes simplex Virus Types 1 and 2 Proteins Synthesis in Cell Culture
by: R. R. Klimova, et al.
Published: (2020-05-01)

DETERMINACIÓN DE LA POTENCIA DEL COMPONENTE SARAMPIÓN DE LA VACUNA DE VIRUS VIVO DE SARAMPIÓN Y RUBÉOLA USP UTILIZADA EN LA JORNADA DE VACUNACIÓN 2005
by: A. Bermúdez-Forero, et al.
Published: (2007-12-01)

Wild Brazilian yellow fever virus infection in Syrian hamsters (Mesocricetus auratus): Clinical and histopathological analyses
by: Fernanda de Oliveira Bottino, et al.
Published: (2024-12-01)

Recombinant erythropoietin in the treatment of anemia in cancer patients
by: S. V. Vorobiova, et al.
Published: (2022-11-01)

Antiviral Activity of Kagocel<sup>®</sup> in vitro Against Virus SARS-CoV-2
by: S. Ya. Loginova, et al.
Published: (2020-06-01)

BORAGE OIL RICH IN GAMMA LINOLENIC ACID (GLA) REDUCES CARDIOVASCULAR DISEASE (CVD) RISK FACTORS IN HAMSTERS FED IN DIET RICH IN SATURATED FATTY ACIDS (SFAS) AND CHOLESTEROL.
by: Ahmad Mufeed Supuh, et al.
Published: (2014-12-01)

Hemangiossarcoma cutâneo em Phodopus roborovskii
by: Ana Carolyne Borges de Oliveira, et al.
Published: (2025-01-01)

Increased inflammation with crude E. coli LPS protects against acute leptospirosis in hamsters
by: Wenlong Zhang, et al.
Published: (2020-01-01)

Development of a hamster model of spontaneous hypertriglyceridemia in diabetes
by: Ya‐Hong Ma, et al.
Published: (2024-12-01)

Intensification of Vero cell adherence to microcarrier particles during cultivation in a wave bioreactor
by: Z. K. Mazhed, et al.
Published: (2025-02-01)

Ultrastructural organization and reproduction of virions in Vero (E6) cells in influenza A/H1N1 pmd09 virus monoinfection and coinfection with SARS-CoV-2 (Delta and Omicron strains)
by: Ksenia F. Emtsova, et al.
Published: (2025-07-01)

Identification of cellular signatures associated with chinese hamster ovary cell adaptation for secretion of antibodies
by: Ying Bai, et al.
Published: (2025-01-01)

Local antiviral activity of the drug «Thymogen®», nasal dosed spray, against SARS-CoV-2 coronavirus <i>in vitro</i>
by: I. A. Leneva, et al.
Published: (2021-08-01)